A Gold Nanoparticle-based Aptasensor for Specific Detection of CA125

An Aptasensor for CA125

Authors

  • Ghasem Ebrahimi 1-Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran/ 2-Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  • Parvin Samadi Pakchin Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
  • Maryam Mousivand Microbial Biotechnology Department, Agricultural Biotechnology Research Institute of Iran, Agricultural Research, Education and Extension Organization, Karaj, Iran
  • Amirabbas Jalili Bolhasani Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  • Ali Mota Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

DOI:

https://doi.org/10.31661/gmj.v13i.3180

Keywords:

Aptamer, Label-free Aptasensor, AuNP Aggregation, Ovarian Cancer, CA-125 Antigen

Abstract

Background: In this work, an aptamer-based biosensor was successfully developed based on the salt-induced gold nanoparticle (AuNP) aggregation phenomenon for the detection of carbohydrate antigen 125 (CA125), which is an important tumor marker for ovarian cancer. Materials and Methods: Citrate-coated AuNPs are relatively highly dispersed NPs. In the presence of different salts, the electrostatic stability of NPs is reduced, and depending on the type of salt and its concentration, different degrees of aggregation occur. On the other hand, the aptamer is easily adsorbed on the AuNP surface and can prevent salt-induced AuNP aggregation. This phenomenon was used in this study to develop a simple biosensor for the detection of CA125. Results: In the presence of CA125, the aptamer was desorbed from the AuNP surface to bind to its antigen due to the higher affinity, leading to the aggregation of AuNPs and a change in the absorption spectra of the solution. Under the optimum condition, the fabricated aptasensor showed a linear range of 15-160 U/mL with a limit of detection (LOD) of 14.41 U/mL. Conclusion: The aptasensor exhibited good repeatability with notable selectivity with regard to CA125 detection, even in human serum samples, as compared to the enzyme-linked immunosorbent assay (ELISA). In conclusion, the engineered aptasensor can serve as a promising tool for the simple, rapid, and cost-effective detection of CA125.

References

Wang Y, Wu R, Cho KR, Thomas DG, Gossner G, Liu JR et al. Differential Protein Mapping of Ovarian Serous Adenocarcinomas: Identification of Potential Markers for Distinct Tumor Stage. J Proteome Res. 2009;8(3):1452-63.

https://doi.org/10.1021/pr800820z

PMid:19159301 PMCid:PMC2693455

Cramer DW. The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin. 2012;26(1):1-12.

https://doi.org/10.1016/j.hoc.2011.10.009

PMid:22244658 PMCid:PMC3259524

Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer. 2003;3(4):267-75.

https://doi.org/10.1038/nrc1043

PMid:12671665

Ebrahimi G, Pakchin PS, Mota A, Omidian H, Omidi Y. Electrochemical microfluidic paper-based analytical devices for cancer biomarker detection: From 2D to 3D sensing systems. Talanta. 2023:124370.

https://doi.org/10.1016/j.talanta.2023.124370

PMid:36858013

Zhang B, Cai FF, Zhong XY. An overview of biomarkers for the ovarian cancer diagnosis. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):119-23.

https://doi.org/10.1016/j.ejogrb.2011.04.023

PMid:21632171

Suh KS, Park SW, Castro A, Patel H, Blake P, Liang M et al. Ovarian cancer biomarkers for molecular biosensors and translational medicine. Expert Rev Mol Diagn. 2010;10(8):1069-83.

https://doi.org/10.1586/erm.10.87

PMid:21080822

Perez BH, Gipson IK. Focus on molecules: human mucin MUC16. Exp Eye Res. 2008;87(5):400.

https://doi.org/10.1016/j.exer.2007.12.008

PMid:18289532 PMCid:PMC2586928

Bast Jr RC, Klug TL, John ES, Jenison E, Niloff JM, Lazarus H et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. NEJM. 1983;309(15):883-7.

https://doi.org/10.1056/NEJM198310133091503

PMid:6310399

Jin H, Gui R, Gong J, Huang W. Aptamer and 5-fluorouracil dual-loading Ag2S quantum dots used as a sensitive label-free probe for near-infrared photoluminescence turn-on detection of CA125 antigen. Biosens Bioelectron. 2017;92:378-84.

https://doi.org/10.1016/j.bios.2016.10.093

PMid:27836590

Miralles C, Orea M, Espana P, Provencio M, Sánchez A, Cantos B et al. Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol. 2003;10:150-4.

https://doi.org/10.1245/ASO.2003.05.015

PMid:12620910

Ren X, Wang H, Wu D, Fan D, Zhang Y, Du B et al. Ultrasensitive immunoassay for CA125 detection using acid site compound as signal and enhancer. Talanta. 2015;144:535-41.

https://doi.org/10.1016/j.talanta.2015.06.086

PMid:26452859

Scholler N, Crawford M, Sato A, Drescher CW, O'Briant KC, Kiviat N et al. Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res. 2006;12(7):2117-24.

https://doi.org/10.1158/1078-0432.CCR-05-2007

PMid:16609024 PMCid:PMC2734269

Chen Z, Zheng W, Huang P, Tu D, Zhou S, Huang M et al. Lanthanide-doped luminescent nano-bioprobes for the detection of tumor markers. Nanoscale. 2015;7(10):4274-90.

https://doi.org/10.1039/C4NR05697C

PMid:25532615

Wang J, Ren J. A sensitive and rapid immunoassay for quantification of CA125 in human sera by capillary electrophoresis with enhanced chemiluminescence detection. Electrophor. 2005;26(12):2402-8.

https://doi.org/10.1002/elps.200410246

PMid:15895464

Shi M, Zhao S, Huang Y, Liu Y-M, Ye F. Microchip fluorescence-enhanced immunoaasay for simultaneous quantification of multiple tumor markers. J Chromatogr B. 2011;879(26):2840-4.

https://doi.org/10.1016/j.jchromb.2011.08.013

PMid:21873123

Xu Q, Li J, Li S, Pan H. A highly sensitive electrochemiluminescence immunosensor based on magnetic nanoparticles and its application in CA125 determination. J Solid State Electrochem. 2012;16:2891-8.

https://doi.org/10.1007/s10008-012-1719-2

Tang M, Wen G, Luo Y, Liang A, Jiang Z. A simple resonance Rayleigh scattering method for determination of trace CA125 using immuno-AuRu nanoalloy as probe via ultrasonic irradiation. Spectrochim Acta A Mol Biomol Spectrosc. 2015;135:1032-8.

https://doi.org/10.1016/j.saa.2014.07.066

PMid:25173519

Hamd-Ghadareh S, Salimi A, Fathi F, Bahrami S. An amplified comparative fluorescence resonance energy transfer immunosensing of CA125 tumor marker and ovarian cancer cells using green and economic carbon dots for bio-applications in labeling, imaging and sensing. Biosens Bioelectron. 2017;96:308-16.

https://doi.org/10.1016/j.bios.2017.05.003

PMid:28525848

Pakchin PS, Ghanbari H, Saber R, Omidi Y. Electrochemical immunosensor based on chitosan-gold nanoparticle/carbon nanotube as a platform and lactate oxidase as a label for detection of CA125 oncomarker. Biosens Bioelectron. 2018;122:68-74.

https://doi.org/10.1016/j.bios.2018.09.016

PMid:30243046

Pakchin PS, Fathi M, Ghanbari H, Saber R, Omidi Y. A novel electrochemical immunosensor for ultrasensitive detection of CA125 in ovarian cancer. Biosens Bioelectron. 2020;153:112029.

https://doi.org/10.1016/j.bios.2020.112029

PMid:31989938

Shayesteh OH, Ghavami R. A novel label-free colorimetric aptasensor for sensitive determination of PSA biomarker using gold nanoparticles and a cationic polymer in human serum. Spectrochim Acta A Mol Biomol Spectrosc. 2020;226:117644.

https://doi.org/10.1016/j.saa.2019.117644

PMid:31614271

Du G, Zhang D, Xia B, Xu L, Wu S, Zhan S et al. A label-free colorimetric progesterone aptasensor based on the aggregation of gold nanoparticles. Mikrochim Acta. 2016;183:2251-8.

https://doi.org/10.1007/s00604-016-1861-0

Zheng Y, Wang Y, Yang X. Aptamer-based colorimetric biosensing of dopamine using unmodified gold nanoparticles. Sens Actuators B Chem. 2011;156(1):95-9.

https://doi.org/10.1016/j.snb.2011.03.077

McKeague M, Foster A, Miguel Y, Giamberardino A, Verdin C, Chan JY et al. Development of a DNA aptamer for direct and selective homocysteine detection in human serum. RSC Adv. 2013;3(46):24415-22.

https://doi.org/10.1039/c3ra43893g

Jazayeri MH, Amani H, Pourfatollah AA, Pazoki-Toroudi H, Sedighimoghaddam B. Various methods of gold nanoparticles (GNPs) conjugation to antibodies. Sens Bio-Sens Res. 2016;9:17-22.

https://doi.org/10.1016/j.sbsr.2016.04.002

Elahi N, Kamali M, Baghersad MH. Recent biomedical applications of gold nanoparticles: A review. Talanta. 2018;184:537-56.

https://doi.org/10.1016/j.talanta.2018.02.088

PMid:29674080

Bohlouli S, Jafarmadar Gharehbagh F, Dalir Abdolahinia E, Kouhsoltani M, Ebrahimi G, Roshangar L et al. Preparation, characterization, and evaluation of rutin nanocrystals as an anticancer agent against head and neck squamous cell carcinoma cell line. J Nanomater. 2021;2021:1-8.

https://doi.org/10.1155/2021/9980451

Wu Y-Y, Huang P, Wu F-Y. A label-free colorimetric aptasensor based on controllable aggregation of AuNPs for the detection of multiplex antibiotics. Food Chem. 2020;304:125377.

https://doi.org/10.1016/j.foodchem.2019.125377

PMid:31476547

Bunka DH, Stockley PG. Aptamers come of age-at last. Nat Rev Microbiol. 2006;4(8):588-96.

https://doi.org/10.1038/nrmicro1458

PMid:16845429

Yoo H, Jo H, Oh SS. Detection and beyond: Challenges and advances in aptamer-based biosensors. Mater Adv. 2020;1(8):2663-87.

https://doi.org/10.1039/D0MA00639D

Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 2005;33(suppl_2):W363-W7.

https://doi.org/10.1093/nar/gki481

PMid:15980490 PMCid:PMC1160241

Yang J, Zhang Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res. 2015;43(W1):W174-W81.

https://doi.org/10.1093/nar/gkv342

PMid:25883148 PMCid:PMC4489253

Mousivand M, Anfossi L, Bagherzadeh K, Barbero N, Mirzadi-Gohari A, Javan-Nikkhah M. In silico maturation of affinity and selectivity of DNA aptamers against aflatoxin B1 for biosensor development. Anal Chim Acta. 2020;1105:178-86.

https://doi.org/10.1016/j.aca.2020.01.045

PMid:32138917

Wang Y-K, Zou Q, Sun J-H, Wang H-a, Sun X, Chen Z-F et al. Screening of single-stranded DNA (ssDNA) aptamers against a zearalenone monoclonal antibody and development of a ssDNA-based enzyme-linked oligonucleotide assay for determination of zearalenone in corn. J Agric Food Chem. 2015;63(1):136-41.

https://doi.org/10.1021/jf503733g

PMid:25485848

Chen X, Huang Y, Duan N, Wu S, Ma X, Xia Y et al. Selection and identification of ssDNA aptamers recognizing zearalenone. Anal Bioanal Chem. 2013;405:6573-81.

https://doi.org/10.1007/s00216-013-7085-9

PMid:23748593

Lu T, Ma Q, Yan W, Wang Y, Zhang Y, Zhao L et al. Selection of an aptamer against Muscovy duck parvovirus for highly sensitive rapid visual detection by label-free aptasensor. Talanta. 2018;176:214-20.

https://doi.org/10.1016/j.talanta.2017.08.037

PMid:28917743

Marcos-Silva L, Narimatsu Y, Halim A, Campos D, Yang Z, Tarp MA et al. Characterization of binding epitopes of CA125 monoclonal antibodies. J Proteome Res. 2014;13(7):3349-59.

https://doi.org/10.1021/pr500215g

PMid:24850311

Downloads

Published

2024-01-17

How to Cite

Ebrahimi, G., Samadi Pakchin, P., Mousivand, M., Jalili Bolhasani, A., & Mota, A. (2024). A Gold Nanoparticle-based Aptasensor for Specific Detection of CA125: An Aptasensor for CA125. Galen Medical Journal, 13, e3180. https://doi.org/10.31661/gmj.v13i.3180

Issue

Vol. 13 (2024): 2024: In Progress

Section

Original Article

License

Copyright (c) 2024 Galen Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

https://creativecommons.org/licenses/by/4.0/